The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Circulating free DNA in plasma or serum as biomarker of carcinogenesis: Practical aspects and biological significance
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jahr, S., Hentze, H., Englisch, S., Hardt, D., Fackelmayer, F. O., Hesch, R. D., & Knippers, R. (2001) · PubMed · Cited by 2,169
(1977) · PubMed · Cited by 1,801
Detection and quantification of mutations in the plasma of patients with colorectal tumors
Diehl, F., Li, M., Dressman, D., He, Y., Shen, D., Szabo, S., Diaz, L. A., Goodman, S. N., David, K. A., Juhl, H., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0507904102 · Cited by 1,188
Rapid Clearance of Fetal DNA from Maternal Plasma
Lo, Y. M. D., Zhang, J., Leung, T. N., Lau, T. K., Chang, A. M. Z., & Hjelm, N. M. (1999) · The American Journal of Human Genetics · doi:10.1086/302205 · Cited by 1,157
Esteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921
Neoplastic Characteristics of the DNA Found in the Plasma of Cancer Patients
Stroun, M., Anker, P., Maurice, P., Lyautey, J., Lederrey, C., & Beljanski, M. (2009) · Oncology · doi:10.1159/000226740 · Cited by 733
Detection and characterization of carcinoma cells in the blood
Racila, E., Euhus, D., Weiss, A. J., Rao, C., McConnell, J., Terstappen, L. W. M. M., & Uhr, J. W. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.8.4589 · Cited by 712
Microsatellite alterations in serum DNA of head and neck cancer patients
Nawroz, H., Koch, W., Anker, P., Stroun, M., & Sidransky, D. (1996) · Nature Medicine · doi:10.1038/nm0996-1035 · Cited by 658
Microsatellite alterations in plasma DNA of small cell lung cancer patients
Qi Chen, X., Stroun, M., Magnenat, J.-L., Nicod, L. P., Kurt, A.-M., Lyautey, J., Lederrey, C., & Anker, P. (1996) · Nature Medicine · doi:10.1038/nm0996-1033 · Cited by 647
Gene promoter hypermethylation in tumors and serum of head and neck cancer patients.
Sánchez‐Céspedes, M., Esteller, M., Wu, L. J., Nawroz-Danish, H., Yoo, G., Koch, W. M., Jen, J., Herman, J. G., & Sidransky, D. (2000) · PubMed · Cited by 540
Shapiro, B., Chakrabarty, M., Cohn, E. M., & Leon, S. A. (1983) · Cancer · doi:10.1002/1097-0142(19830601)51:11<2116::aid-cncr2820511127>3.0.co;2-s · Cited by 403
Detection of oncogene mutations in sputum precedes diagnosis of lung cancer
(1994) · Lung Cancer · doi:10.1016/0169-5002(94)92208-x · Cited by 398
Belinsky, S. A., Liechty, K. C., Gentry, F. D., Wolf, H. J., Rogers, J., Vu, K., Haney, J., Kennedy, T. C., Hirsch, F. R., Miller, Y., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3408 · Cited by 389
Diet and cancer — the European Prospective Investigation into Cancer and Nutrition
Bingham, S., & Riboli, E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1298 · Cited by 384
Sozzi, G., Conte, D., Mariani, L., Vullo, S. L., Roz, L., Lombardo, C., Pierotti, M. A., & Tavecchio, L. (2001) · PubMed · Cited by 380
Hypermethylated APC DNA in Plasma and Prognosis of Patients With Esophageal Adenocarcinoma
Kawakami, K. (2000) · Journal of the National Cancer Institute · doi:10.1093/jnci/92.22.1805 · Cited by 376
Isolation and characterization of DNA from the plasma of cancer patients
Stroun, M., Anker, P., Lyautey, J., Lederrey, C., & Maurice, P. A. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90266-5 · Cited by 373
Increased plasma DNA integrity in cancer patients.
Wang, B. G., Huang, H. Y., Chen, Y., Bristow, R. E., Kassauei, K., Cheng, C., Roden, R. B. S., Sokoll, L. J., Chan, D. W., & Shih, I. (2003) · PubMed · Cited by 326
Lee, T., Montalvo, L., Chrebtow, V., & Busch, M. P. (2001) · Transfusion · doi:10.1046/j.1537-2995.2001.41020276.x · Cited by 311
Goessl, C. D., Krause, H., Müller, M., Heicappell, R., Schrader, M. G., Sachsinger, J., & Miller, K. (2000) · PubMed · Cited by 304
Usadel, H., Brabender, J., Danenberg, K. D., Jerónimo, C., Harden, S., Engles, J. M., Danenberg, P. V., Yang, S. S., & Sidransky, D. (2002) · PubMed · Cited by 302
Lecomte, T., Berger, A., Zinzindohoué, F., Micard, S., Landi, B., Blons, H., Beaune, P., Cugnenc, P., & Laurent‐Puig, P. (2002) · International Journal of Cancer · doi:10.1002/ijc.10526 · Cited by 292
Molecular detection of genetic alterations in the serum of colorectal cancer patients.
Hibi, K., Robinson, C. R., Booker, S. V., Wu, L. J., Hamilton, S. R., Sidransky, D., & Jen, J. (1998) · PubMed · Cited by 236
Spontaneous release of DNA by human blood lymphocytes as shown in an in vitro system.
Anker, P., Stroun, M., & Maurice, P. A. (1975) · PubMed · Cited by 234
Rapid p53 sequence analysis in primary lung cancer using an oligonucleotide probe array
Ahrendt, S. A., Halachmi, S., Chow, J. T., Wu, L., Halachmi, N., Yang, S. C., Wehage, S., Jen, J., & Sidransky, D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.13.7382 · Cited by 230
Circulating DNA: a new diagnostic gold mine?
Ziegler, A., Zangemeister-Wittke, U., & Stahel, R. A. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)00077-4 · Cited by 228
GRADY, W., RAIPUT, A., LUTTERBAUGH, J., & MARKOWITZ, S. (2001) · Gastroenterology · doi:10.1016/s0016-5085(01)81443-8 · Cited by 224
A prospective study of K-ras mutations in the plasma of pancreatic cancer patients.
Mulcahy, H. E., Lyautey, J., Lederrey, C., Chen, X. Q., Anker, P., Alstead, E. M., Ballinger, A., Farthing, M. J. G., & Stroun, M. (1998) · PubMed · Cited by 205
Detecting tumor-related alterations in plasma or serum DNA of patients diagnosed with breast cancer.
Chen, X., Bonnefoi, H. R., Diebold‐Berger, S., Lyautey, J., Lederrey, C., Faltin-Traub, E. F., Stroun, M., & Anker, P. (1999) · PubMed · Cited by 193
Ser-249 p53 Mutations in Plasma DNA of Patients With Hepatocellular Carcinoma From The Gambia
Kirk, G. D., Camus-Randon, A.-M., Mendy, M., Goedert, J. J., Merle, P., Trépo, C., Bréchot, C., Hainaut, P., & Montesano, R. (2000) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/92.2.148 · Cited by 190
Self-citationNucleosomes in serum of patients with benign and malignant diseases
Holdenrieder, S., Stieber, P., Bodenm�ller, H., Busch, M., Fertig, G., F�rst, H., Schalhorn, A., Schmeller, N., Untch, M., & Seidel, D. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010320)95:2<114::aid-ijc1020>3.0.co;2-q · Cited by 186
Kirk, G. D., Lesi, O. A., Mendy, M., Szymañska, K., Whittle, H., Goedert, J. J., Hainaut, P., & Montesano, R. (2005) · Oncogene · doi:10.1038/sj.onc.1208732 · Cited by 181
Self-citationRaptis, L., & Menard, H. A. (1980) · Journal of Clinical Investigation · doi:10.1172/jci109992 · Cited by 174
Detection of mutant K-ras DNA in plasma or serum of patients with colorectal cancer
Kopreski, M., Benko, F., Kwee, C., Leitzel, K., Eskander, E., Lipton, A., & Gocke, C. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.551 · Cited by 172
Gormally, E., Vineis, P., Matullo, G., Veglia, F., Caboux, E., Le Roux, E., Peluso, M., Garte, S., Guarrera, S., Munnia, A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-4556 · Cited by 164
Self-citationSozzi, G., Roz, L., Conte, D., Mariani, L., Andriani, F., Verderio, P., & Pastorino, U. (2005) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dji432 · Cited by 163
Hibi, K., Taguchi, M., Nakayama, H., Takase, T., Kasai, Y., Ito, K., Akiyama, S., & Nakao, A. (2001) · PubMed · Cited by 160
Bearzatto, A., Conte, D., Frattini, M., Zaffaroni, N., Andriani, F., Balestra, D., Tavecchio, L., Daidone, M. G., & Sozzi, G. (2002) · PubMed · Cited by 144
Silva, J. M., Silva, J., Sánchez, A., Garcia, J. M., Domínguez, G., Provencio, M., Sanfrutos, L., Jareño, E., Colas, A., España, P., et al. (2002) · PubMed · Cited by 142
Sozzi, G., Musso, K., Ratcliffe, C., Goldstraw, P. G., Pierotti, M. A., & Pastorino, U. (1999) · PubMed · Cited by 138
KOPRESKI, M. S., Benko, F. A., Borys, D. J., Khan, A., McGarrity, T. J., & Gocke, C. D. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.11.918 · Cited by 134
Assessment of Plasma DNA Levels, Allelic Imbalance, and CA 125 as Diagnostic Tests for Cancer
Chang, H. W. (2002) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/94.22.1697 · Cited by 132
An Overview on the Isolation and Analysis of Circulating Tumor DNA in Plasma and Serum
Jen, J., Wu, L. J., & Sidransky, D. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06581.x · Cited by 128
Utting, M., Werner, W., Dahse, R., Schubert, J., & Junker, K. (2002) · PubMed · Cited by 115
Domínguez, G., Carballido, J., Silva, J., Silva, J. M., García, J. M., Menéndez, J., Provencio, M., España, P., & Bonilla, F. (2002) · PubMed · Cited by 114
Wong, I. H. N., Zhang, J., Lai, P. B. S., Lau, W. Y., & Lo, Y. M. D. (2003) · PubMed · Cited by 113
Flaman, J., Frébourg, T., Moreau, V., Charbonnier, F., Martin, C., Ishioka, C., Friend, S. H., & Iggo, R. D. (1994) · Nucleic Acids Research · doi:10.1093/nar/22.15.3259 · Cited by 112
Szymańska, K., Lesi, O. A., Kirk, G. D., Sam, O., Tanière, P., Scoazec, J., Mendy, M. E., Friesen, M. D., Whittle, H. C., Montesano, R., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20103 · Cited by 109
Self-citationRothman, N., Stewart, W. F., & Schulte, P. A. (1995) · PubMed · Cited by 109
Ryan, B. M., Lefort, F., McManus, R., Daly, J., Keeling, P. W. N., Weir, D. G., & Kelleher, D. (2002) · Gut · doi:10.1136/gut.52.1.101 · Cited by 109
Prospective detection of codon 249 mutations in plasma of hepatocellular carcinoma patients
Jackson, P. E. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg101 · Cited by 105
Jackson, P. E., Qian, G., Friesen, M. D., Zhu, Y. R., Lu, P., Wang, J. B., Wu, Y., Kensler, T. W., Vogelstein, B., & Groopman, J. D. (2001) · PubMed · Cited by 105
Genotyping by mass spectrometric analysis of short DNA fragments
Laken, S. J., Jackson, P. E., Kinzler, K. W., Vogelstein, B., Strickland, P. T., Groopman, J. D., & Friesen, M. D. (1998) · Nature Biotechnology · doi:10.1038/4333 · Cited by 102
Evaluating the arrayed primer extension resequencing assay of TP53 tumor suppressor gene
Tõnisson, N., Zernant, J., Kurg, A., Pavel, H., Slavin, G., Roomere, H., Meiel, A., Hainaut, P. L., & Metspalu, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082100599 · Cited by 97
Self-citationPlasma DNA microsatellite panel as sensitive and tumor‐specific marker in lung cancer patients
Beau‐Faller, M., Gaub, M. P., Schneider, A., Ducrocq, X., Massard, G., Gasser, B., Gaub, M. P., Kessler, R., Anker, P., Stroun, M., et al. (2003) · International Journal of Cancer · doi:10.1002/ijc.11079 · Cited by 95
Coulet, F., Blons, H., Cabelguenne, A., Lecomte, T., Lacourreye, O., Brasnu, D. F., Beaune, P. H., Zucman‐Rossi, J., & Laurent‐Puig, P. (2000) · PubMed · Cited by 93
Amount of DNA in plasma and cancer risk: A prospective study
Gormally, E., Hainaut, P. L., Caboux, É., Airoldi, L., Autrup, H. N., MALAVEILLE, C., Dunning, A. M., GARTE, S. J., Matullo, G., Overvad, K., et al. (2004) · International Journal of Cancer · doi:10.1002/ijc.20327 · Cited by 93
Self-citationAssessing the Use of p16INK4a Promoter Gene Methylation in Serum for Detection of Bladder Cancer
Valenzuela, M., Galisteo, R., Zuluaga, A., Villalobos, M., Núñez, M. I., Oliver, F. J., & de Almodóvar, J. M. R. (2002) · European Urology · doi:10.1016/s0302-2838(02)00468-2 · Cited by 82
Molecular detection of p16 promoter methylation in the serum of recurrent colorectal cancer patients
Nakayama, H., Hibi, K., Takase, T., Yamazaki, T., Kasai, Y., Ito, K., Akiyama, S., & Nakao, A. (2003) · International Journal of Cancer · doi:10.1002/ijc.11117 · Cited by 78
Apoptosis in serum of patients with solid tumours.
Holdenrieder, S., Stieber, P., Förg, T., Kühl, M., Schulz, L., Busch, M., Schalhorn, A., & Seidel, D. (1999) · PubMed · Cited by 70
Radioimmunoassay for nanogram quantities of DNA
Leon, S. A., Green, A., Yaros, M. J., & Shapiro, B. (1975) · Journal of Immunological Methods · doi:10.1016/0022-1759(75)90106-4 · Cited by 64
Genetic alterations in bronchial mucosa and plasma DNA from individuals at high risk of lung cancer
Allan, J. M., Hardie, L. J., Briggs, J., Davidson, L. A., Watson, J. P., Pearson, S. B., Muers, M. F., & Wild, C. P. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(200002)9999:9999<::aid-ijc1058>3.0.co;2-e · Cited by 58
Circulating DNA in Plasma or Serum
Anker, P., & Stroun, M. (2001) · KARGER eBooks · doi:10.1159/000062524 · Cited by 57
Chang, H. W., Chan, A., Kwong, D. L. �., Wei, W., Sham, J. S. T., & Yuen, A. P. W. (2003) · PubMed · Cited by 49
Quantitative Analysis of Plasma TP53 249Ser-Mutated DNA by Electrospray Ionization Mass Spectrometry
LLeonart, M. E., Kirk, G. D., Villar, S., Lesi, O. A., Dasgupta, A., Goedert, J. J., Mendy, M. E., Hollstein, M. C., Montesano, R., Groopman, J. D., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0612 · Cited by 47
Self-citationSjöholm, M., Hoffmann, G., Lindgren, S. C., Dillner, J., & Carlson, J. A. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.251.14.1 · Cited by 45
Wong, I. H. N., Lo, Y. M. D., Lai, P. B. S., & Johnson, P. J. (2000) · Clinical Chemistry · doi:10.1093/clinchem/46.9.1420 · Cited by 44
Cell-free DNA and RNA in plasma as new tools for molecular diagnostics
Wong, B. C. K., & Lo, Y. M. D. (2003) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.3.6.785 · Cited by 31
Fournié, G. J., Gayral-Taminh, M., Bouché, J.-P., & Conté, J. J. (1986) · Analytical Biochemistry · doi:10.1016/0003-2697(86)90545-2 · Cited by 27
Diagnostic potential of circulating nucleic acids for oncology
Goessl, C. D. (2003) · Expert Review of Molecular Diagnostics · doi:10.1586/14737159.3.4.431 · Cited by 26
Jenkins, G. J. S., Doak, S. H., Griffiths, A. P., Tofazzal, N., Shah, V., BAXTER, J. N., & Parry, J. M. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6600891 · Cited by 22
Jacobs, G., Tscholl, E., Sek, A., Pfreundschuh, M. G., Daus, H., & Trümper, L. H. P. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050292 · Cited by 21
Salbe, C., Trevisiol, C., Ferruzzi, E., Mancuso, T., Nascimbeni, R., Fabio, F. D., Salerni, B., & Dittadi, R. (2000) · The International Journal of Biological Markers · doi:10.1177/172460080001500404 · Cited by 19
Calvez‐Kelm, F. L., Ahman, A., Tõnisson, N., Lambert, J., Temam, S., Brennan, P., Zaridze, D. G., Metspalu, A., & Hainaut, P. L. (2005) · Clinical Chemistry · doi:10.1373/clinchem.2005.048348 · Cited by 18
Self-citation
Cited by
ESMO consensus guidelines for the management of patients with metastatic colorectal cancer
Van Cutsem, E., Cervantes, A., Adam, R., Sobrero, A., Van Krieken, J. H., Aderka, D., Aranda Aguilar, E., Bardelli, A., Benson, A., Bodoky, G., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw235 · Cited by 3,421
Liquid biopsies come of age: Towards implementation of circulating tumour DNA
Wan, J. C. M., Massie, C., Garcia-Corbacho, J., Mouliere, F., Brenton, J. D., Caldas, C., Pacey, S., Baird, R., & Rosenfeld, N. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.7 · Cited by 2,809
Circulating mutant DNA to assess tumor dynamics
Diehl, F., Schmidt, K., Choti, M. A., Romans, K., Goodman, S., Li, M., Thornton, K., Agrawal, N., Sokoll, L., Szabo, S. A., et al. (2008) · Nature Medicine · doi:10.1038/nm.1789 · Cited by 2,734
Analysis of Circulating Tumor DNA to Monitor Metastatic Breast Cancer
Dawson, S.-J., Tsui, D. W. Y., Murtaza, M., Biggs, H., Rueda, O. M., Chin, S.-F., Dunning, M. J., Gale, D., Forshew, T., Mahler-Araujo, B., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1213261 · Cited by 2,207
Liquid biopsy: monitoring cancer-genetics in the blood
Crowley, E., Di Nicolantonio, F., Loupakis, F., & Bardelli, A. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.110 · Cited by 1,819
Metadata
- Authors
- Gormally, E., Caboux, E., Vineis, P., & Hainaut, P.
- Venue
- Mutation Research/Reviews in Mutation Research
- Publisher
- Elsevier BV
- Published
- 2007-05
- Volume
- 635
- Issue
- 2-3
- Pages
- 105-117
- ISSN
- 1383-5742 (ISSN-L)
- OpenAlex
- W2088164932
- Cited by
- 445
- References
- 74
- FWCI
- 5.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.